Cytokinetics (CYTK) Revenue Growth (3y) (2013 - 2026)
Cytokinetics (CYTK) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 979.48% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 42.02% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -91.03% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 7.80% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 59.40% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 76.62% |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 220.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 220.80% |
| Mar 31, 2026 | 61.29% |
| Dec 31, 2025 | 108.57% |
| Sep 30, 2025 | -8.35% |
| Jun 30, 2025 | -9.12% |
| Mar 31, 2025 | 11.21% |
| Dec 31, 2024 | -27.93% |
| Sep 30, 2024 | -56.00% |
| Jun 30, 2024 | -55.59% |
| Mar 31, 2024 | -49.67% |
| Dec 31, 2023 | 28.72% |
| Sep 30, 2023 | -79.15% |
| Jun 30, 2023 | -37.74% |
| Mar 31, 2023 | 6.44% |
| Dec 31, 2022 | -27.86% |
| Sep 30, 2022 | -25.39% |
| Jun 30, 2022 | 131.87% |
| Mar 31, 2022 | -48.62% |
| Dec 31, 2021 | 62.28% |
| Sep 30, 2021 | -20.05% |